Control CD4+CD25+ T cells from control subjects were also subjected to the same extended standard and TNF and TNFR2 agonist supplemental expansion protocol to determine whether there was any difference between T1D and controls. This evidence concerns the gene CD4 and type 1 diabetes mellitus.